Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Havlucu (Manisa, Turkey). Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma.. 4021

Member's Comments

No comment yet.

Related content which might interest you: Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Evaluation of Asthma control and oral corticosteroids in Severe Asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Effects of MACVIA-ARIA Sentinel Network for Allergic Rhinitis (MASK-Air) Mobile Phone Application on Asthma Control in Patients with Asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma Source: International Congress 2018 – Asthma analysis Year: 2018 Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Efficacy of Occupational Therapy in patients with COPD Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Prescribing Trends of Oral Corticosteroids Among Young Adults with Active Asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Guideline Adherence and Identifying Cost Effective Medication Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Efficacy and safety of fluticasone propionate/formoterol in paediatric patients with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Occupational Performance in Patients with Bronchial Asthma Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1 Year: 2020